| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |